Youssef L. Bennani, PhD
Dr. Youssef L. Bennani joined the Board of BELLUS Health in May 2017.
Dr. Bennani is a pharmaceutical executive and currently serves as Managing Partner at CTI Life Sciences, a Venture Capital firm; Chief Executive Officer of Find Therapeutics, and Neurasic Therapeutics; as well Chief Scientific Officer of adMare BioInnovations, the sole member of the Neomed Institute.
Dr. Bennani was Vice-President of R&D at Vertex Canada. Prior, to that he was VP-Drug Innovation at Vertex Pharmaceuticals in Boston. Over the past 25 years, he held various positions of increasing responsibility in pharmaceutical R&D for nearly 25 years in the USA and Canada (Ligand Pharmaceuticals, Abbott Laboratories (now Abbvie), and Athersys). Over this span, he worked in the fields of oncology, neurology, immunology and infection. In 2011 he received an honorary degree from the Université de Montréal for his contribution to Society.
He received a Doctorate degree (Ph.D., ‘91) in chemistry from Université de Montréal, a post-doctoral studies at The Scripps Research Institute in La Jolla, California, as well as an Executive-MBA (2000) from LFGSM in Chicago, Illinois. In addition, he is an accredited Director from the Institute of Corporate Directors (ICD.D) from McGill-Rotman Schools of Business.